Sino Biopharmaceutical Limited (SBHMY)

Sino Biopharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 30, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	15,619	7,500	8,173	10,832	13,133	18,176
Market Cap Growth	130.68%	-8.23%	-24.55%	-17.52%	-27.74%	3.57%
Enterprise Value	16,255	8,299	8,498	11,564	14,636	18,844
Last Close Price	15.89	8.21	9.12	11.07	13.57	16.82
PE Ratio	28.90	15.64	24.85	29.37	5.71	42.82
PS Ratio	3.66	1.90	2.21	2.87	3.11	5.02
PB Ratio	2.44	1.28	1.52	1.97	2.21	5.29
P/TBV Ratio	3.70	1.78	1.96	2.59	2.84	7.22
P/FCF Ratio	19.05	9.68	11.60	14.88	22.84	30.42
P/OCF Ratio	16.71	8.28	9.55	11.93	15.55	22.28
EV/Sales Ratio	3.79	2.10	2.30	3.07	3.46	5.20
EV/EBITDA Ratio	16.68	8.79	9.45	12.75	17.05	21.73
EV/EBIT Ratio	20.31	10.44	11.08	14.81	20.07	30.02
EV/FCF Ratio	19.82	10.71	12.06	15.88	25.46	31.54
Debt / Equity Ratio	0.26	0.23	0.33	0.37	0.33	0.63
Debt / EBITDA Ratio	1.71	1.39	1.97	2.22	2.21	2.48
Debt / FCF Ratio	2.04	1.72	2.54	2.81	3.36	3.64
Asset Turnover	0.43	0.45	0.41	0.42	0.50	0.56
Inventory Turnover	2.83	2.44	2.31	2.10	2.79	2.93
Quick Ratio	1.14	1.11	0.90	1.15	1.38	1.87
Current Ratio	1.36	1.26	1.05	1.29	1.53	2.08
Return on Equity (ROE)	15.40%	11.82%	12.12%	11.94%	55.25%	20.20%
Return on Assets (ROA)	5.07%	5.62%	5.33%	5.40%	5.37%	6.05%
Return on Invested Capital (ROIC)	13.43%	14.13%	12.90%	13.46%	15.24%	23.45%
Return on Capital Employed (ROCE)	11.50%	12.70%	13.30%	12.30%	10.30%	11.30%
Earnings Yield	3.46%	6.39%	4.02%	3.40%	17.51%	2.33%
FCF Yield	5.25%	10.33%	8.62%	6.72%	4.38%	3.29%
Dividend Yield	1.23%	0.11%	0.07%	0.14%	0.08%	0.06%
Payout Ratio	47.69%	52.76%	27.13%	49.84%	6.42%	42.84%
Buyback Yield / Dilution	2.10%	1.26%	2.57%	1.38%	-2.57%	0.06%
Total Shareholder Return	3.33%	1.37%	2.64%	1.52%	-2.49%	0.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.